Vyloo

Docosahexanoic Acid Dha 100mg medicines online

About Docosahexanoic Acid Dha 100mg

Docosahexanoic Acid Dha 100mg appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
Folok-DHA CapsuleRx

Folok-DHA Capsule

Agoc Care Pvt Ltd · 10.0 soft gelatin capsules in 1 strip

₹185
Ixofol-DHA Softgel CapsuleRx

Ixofol-DHA Softgel Capsule

Aleixo Pharma · 10.0 soft gelatin capsules in 1 strip

₹227
MAF-DHA Softgel CapsuleRx

MAF-DHA Softgel Capsule

Tms India Pvt Ltd · 10.0 soft gelatin capsules in 1 strip

₹225
Foltix DHA Softgel CapsuleRx

Foltix DHA Softgel Capsule

Fibovil Pharmaceuticals Pvt Ltd · 10.0 soft gelatin capsules in 1 strip

₹197
Rolifol-Dha Softgel CapsuleRx

Rolifol-Dha Softgel Capsule

Rollick Healthcare Pvt Ltd · 15.0 soft gelatin capsules in 1 strip

₹202
Folraise-DHA Softgel CapsuleRx

Folraise-DHA Softgel Capsule

Aexiom Pharmaceuticals · 15.0 soft gelatin capsules in 1 strip

₹155
Foligrace-DHA Softgel CapsuleRx

Foligrace-DHA Softgel Capsule

Leeford Healthcare Ltd · 10.0 soft gelatin capsules in 1 strip

₹165
Zeliroz-DHA Softgel CapsuleNon-Rx

Zeliroz-DHA Softgel Capsule

Aestivus Healthcare Pvt Ltd · 10.0 soft gelatin capsules in 1 strip

₹173
Folvite DHA Soft Gelatin Capsule10% offRx

Folvite DHA Soft Gelatin Capsule

Pfizer Ltd · 10.0 soft gelatin capsules in 1 strip

₹246₹274
Ambifol-Dha Soft Gelatin CapsuleRx

Ambifol-Dha Soft Gelatin Capsule

Dewcare Concept Pvt.Ltd. · 10.0 soft gelatin capsules in 1 strip

₹163
I-dew Mega Soft Gelatin CapsuleNon-Rx

I-dew Mega Soft Gelatin Capsule

Entod Pharmaceuticals Ltd · 10.0 soft gelatin capsules in 1 strip

₹279
Foligood-D TabletRx

Foligood-D Tablet

Foregen Healthcare Ltd · 10.0 tablets in 1 strip

₹204

Frequently asked questions

All salts · Health conditions · Editorial policy